Copyright Reports & Markets. All rights reserved.

Global Nausea And Vomiting Treatment Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Nausea And Vomiting Treatment Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Serotonin Receptor Antagonist
      • 1.4.3 Neurokinin NK1 Receptor Antagonist
      • 1.4.4 Other
    • 1.5 Market by Application
      • 1.5.1 Global Nausea And Vomiting Treatment Market Share by Application (2019-2025)
      • 1.5.2 CINV
      • 1.5.3 PONV
      • 1.5.4 Motion Sickness
      • 1.5.5 Pregnancy
      • 1.5.6 Others
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Nausea And Vomiting Treatment Market Size
    • 2.2 Nausea And Vomiting Treatment Growth Trends by Regions
      • 2.2.1 Nausea And Vomiting Treatment Market Size by Regions (2019-2025)
      • 2.2.2 Nausea And Vomiting Treatment Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Challenges
      • 2.3.4 Porter’s Five Forces Analysis

    3 Market Share by Key Players

    • 3.1 Nausea And Vomiting Treatment Market Size by by Players
      • 3.1.1 Global Nausea And Vomiting Treatment Revenue by by Players (2014-2019)
      • 3.1.2 Global Nausea And Vomiting Treatment Revenue Market Share by by Players (2014-2019)
      • 3.1.3 Global Nausea And Vomiting Treatment Market Concentration Ratio (CR5 and HHI)
    • 3.2 Nausea And Vomiting Treatment Key Players Head office and Area Served
    • 3.3 Key Players Nausea And Vomiting Treatment Product/Solution/Service
    • 3.4 Date of Enter into Nausea And Vomiting Treatment Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Nausea And Vomiting Treatment Market Size by Type (2014-2019)
    • 4.2 Global Nausea And Vomiting Treatment Market Size by Application (2014-2019)

    5 North America

    • 5.1 North America Nausea And Vomiting Treatment Market Size (2014-2019)
    • 5.2 Nausea And Vomiting Treatment Key Players in North America
    • 5.3 North America Nausea And Vomiting Treatment Market Size by Type
    • 5.4 North America Nausea And Vomiting Treatment Market Size by Application

    6 Europe

    • 6.1 Europe Nausea And Vomiting Treatment Market Size (2014-2019)
    • 6.2 Nausea And Vomiting Treatment Key Players in Europe
    • 6.3 Europe Nausea And Vomiting Treatment Market Size by Type
    • 6.4 Europe Nausea And Vomiting Treatment Market Size by Application

    7 China

    • 7.1 China Nausea And Vomiting Treatment Market Size (2014-2019)
    • 7.2 Nausea And Vomiting Treatment Key Players in China
    • 7.3 China Nausea And Vomiting Treatment Market Size by Type
    • 7.4 China Nausea And Vomiting Treatment Market Size by Application

    8 Japan

    • 8.1 Japan Nausea And Vomiting Treatment Market Size (2014-2019)
    • 8.2 Nausea And Vomiting Treatment Key Players in Japan
    • 8.3 Japan Nausea And Vomiting Treatment Market Size by Type
    • 8.4 Japan Nausea And Vomiting Treatment Market Size by Application

    9 International Players Profiles

    • 9.1 Merck & Co. Inc.
      • 9.1.1 Merck & Co. Inc. Company Details
      • 9.1.2 Company Description and Business Overview
      • 9.1.3 Nausea And Vomiting Treatment Introduction
      • 9.1.4 Merck & Co. Inc. Revenue in Nausea And Vomiting Treatment Business (2014-2019))
      • 9.1.5 Merck & Co. Inc. Recent Development
    • 9.2 Helsinn Group
      • 9.2.1 Helsinn Group Company Details
      • 9.2.2 Company Description and Business Overview
      • 9.2.3 Nausea And Vomiting Treatment Introduction
      • 9.2.4 Helsinn Group Revenue in Nausea And Vomiting Treatment Business (2014-2019)
      • 9.2.5 Helsinn Group Recent Development
    • 9.3 Unimed Pharmaceuticals (AbbVie Inc.)
      • 9.3.1 Unimed Pharmaceuticals (AbbVie Inc.) Company Details
      • 9.3.2 Company Description and Business Overview
      • 9.3.3 Nausea And Vomiting Treatment Introduction
      • 9.3.4 Unimed Pharmaceuticals (AbbVie Inc.) Revenue in Nausea And Vomiting Treatment Business (2014-2019)
      • 9.3.5 Unimed Pharmaceuticals (AbbVie Inc.) Recent Development
    • 9.4 Kyowa Kirin
      • 9.4.1 Kyowa Kirin Company Details
      • 9.4.2 Company Description and Business Overview
      • 9.4.3 Nausea And Vomiting Treatment Introduction
      • 9.4.4 Kyowa Kirin Revenue in Nausea And Vomiting Treatment Business (2014-2019)
      • 9.4.5 Kyowa Kirin Recent Development
    • 9.5 Sanofi
      • 9.5.1 Sanofi Company Details
      • 9.5.2 Company Description and Business Overview
      • 9.5.3 Nausea And Vomiting Treatment Introduction
      • 9.5.4 Sanofi Revenue in Nausea And Vomiting Treatment Business (2014-2019)
      • 9.5.5 Sanofi Recent Development
    • 9.6 Qilu Pharma
      • 9.6.1 Qilu Pharma Company Details
      • 9.6.2 Company Description and Business Overview
      • 9.6.3 Nausea And Vomiting Treatment Introduction
      • 9.6.4 Qilu Pharma Revenue in Nausea And Vomiting Treatment Business (2014-2019)
      • 9.6.5 Qilu Pharma Recent Development
    • 9.7 Teva Pharmaceutical Industries Ltd.
      • 9.7.1 Teva Pharmaceutical Industries Ltd. Company Details
      • 9.7.2 Company Description and Business Overview
      • 9.7.3 Nausea And Vomiting Treatment Introduction
      • 9.7.4 Teva Pharmaceutical Industries Ltd. Revenue in Nausea And Vomiting Treatment Business (2014-2019)
      • 9.7.5 Teva Pharmaceutical Industries Ltd. Recent Development
    • 9.8 Taiji group
      • 9.8.1 Taiji group Company Details
      • 9.8.2 Company Description and Business Overview
      • 9.8.3 Nausea And Vomiting Treatment Introduction
      • 9.8.4 Taiji group Revenue in Nausea And Vomiting Treatment Business (2014-2019)
      • 9.8.5 Taiji group Recent Development
    • 9.9 Novartis
      • 9.9.1 Novartis Company Details
      • 9.9.2 Company Description and Business Overview
      • 9.9.3 Nausea And Vomiting Treatment Introduction
      • 9.9.4 Novartis Revenue in Nausea And Vomiting Treatment Business (2014-2019)
      • 9.9.5 Novartis Recent Development
    • 9.10 Heron Therapeutics
      • 9.10.1 Heron Therapeutics Company Details
      • 9.10.2 Company Description and Business Overview
      • 9.10.3 Nausea And Vomiting Treatment Introduction
      • 9.10.4 Heron Therapeutics Revenue in Nausea And Vomiting Treatment Business (2014-2019)
      • 9.10.5 Heron Therapeutics Recent Development
    • 9.11 Atnahs Pharma UK Limited
    • 9.12 Mylan
    • 9.13 Duchesnay
    • 9.14 Tesaro

    10 Market Forecast 2019-2025

    • 10.1 Market Size Forecast by Product (2019-2025)
    • 10.2 Market Size Forecast by Application (2019-2025)
    • 10.3 Market Size Forecast by Regions
    • 10.4 North America
    • 10.5 Europe
    • 10.6 China
    • 10.7 Japan

    11 Analyst's Viewpoints/Conclusions

      12 Appendix

      • 12.1 Research Methodology
        • 12.1.1 Methodology/Research Approach
          • 12.1.1.1 Research Programs/Design
          • 12.1.1.2 Market Size Estimation
          • 12.1.1.3 Market Breakdown and Data Triangulation
        • 12.1.2 Data Source
          • 12.1.2.1 Secondary Sources
          • 12.1.2.2 Primary Sources
      • 12.2 Disclaimer

      This report focuses on the global Nausea And Vomiting Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Nausea And Vomiting Treatment development in North America, Europe, China and Japan.

      The key players covered in this study
      Merck & Co. Inc.
      Helsinn Group
      Unimed Pharmaceuticals (AbbVie Inc.)
      Kyowa Kirin
      Sanofi
      Qilu Pharma
      Teva Pharmaceutical Industries Ltd.
      Taiji group
      Novartis
      Heron Therapeutics
      Atnahs Pharma UK Limited
      Mylan
      Duchesnay
      Tesaro

      Market segment by Type, the product can be split into
      Serotonin Receptor Antagonist
      Neurokinin NK1 Receptor Antagonist
      Other

      Serotonin Receptor Antagonist had the biggest market share of 61% in 2018.

      Market segment by Application, split into
      CINV
      PONV
      Motion Sickness
      Pregnancy
      Others

      CINV is the greatest segment of Nausea And Vomiting Treatment application, with a share of 49% in 2018.

      Market segment by Regions/Countries, this report covers
      North America
      Europe
      China
      Japan

      The study objectives of this report are:
      To analyze global Nausea And Vomiting Treatment status, future forecast, growth opportunity, key market and key players.
      To present the Nausea And Vomiting Treatment development in North America, Europe, China and Japan.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Nausea And Vomiting Treatment are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now